Developing Innovation Ecosystems with Novant Health and Alexion Pharmaceuticals

May 6, 2021

More Ways to Listen

LISTEN TO PODCAST

Subscribe on Your Favorite Platform

Other Platforms

About the Guest

Angela Yochem & George Llado

EVP and Chief Transformation & Digital Officer of Novant Health; SVP and CIO, Alexion Pharmaceuticals

Angela Yochem is the EVP and Chief Transformation & Digital Officer at Novant Health, an integrated healthcare provider with annual revenues exceeding $7 billion annually. Prior to joining Novant Health, Angela held CIO roles at Rent-A-Center, BDP International and was the Chief Technology Officer of AstraZeneca. George Llado is the SVP and CIO of Alexion Pharmaceuticals, a $7 billion revenue organization focused on serving patients and families affected by rare diseases by providing highly innovative, life-changing therapies for the diseases it treats. Prior to joining Alexion, George spent 25 years at Merck & Co.

Episode Overview

556: In this interview, Angela Yochem, the EVP and Chief Transformation & Digital Officer at Novant Health, and George Llado, the SVP and CIO of Alexion Pharmaceuticals, focus on the power of ecosystems. Angela discusses the importance of leveraging ecosystems to drive innovation at scale, and she shares the story of how Novant Health formed an “unconventional partnership” with Stewart-Haas to build ICU carts for overrun hospitals. Meanwhile, George discusses Alexion’s strategy of cultivating relationships with startups and venture capital firms to accelerate innovation, as well as his approach to strategic planning.

Developing Innovation Ecosystems with Novant Health and Alexion Pharmaceuticals

About the Guest

Angela Yochem & George Llado

Episode Overview

Share On Your Favorite Platform

Related Podcasts